TLDR XRP dropped 3.52% to around $1.40 as broader crypto market fell roughly 2% The SEC faces a final deadline on March 27 to rule on multiple spot XRP ETF applicationsTLDR XRP dropped 3.52% to around $1.40 as broader crypto market fell roughly 2% The SEC faces a final deadline on March 27 to rule on multiple spot XRP ETF applications

XRP Price: Retail Buyers Step In but Whales Stay Quiet Before the Big SEC Decision

2026/03/23 15:38
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

TLDR

  • XRP dropped 3.52% to around $1.40 as broader crypto market fell roughly 2%
  • The SEC faces a final deadline on March 27 to rule on multiple spot XRP ETF applications
  • Retail wallets holding under 100 XRP hit a record high of 5.66 million
  • Whale wallets holding over 100,000 XRP remain flat at 32,054, suggesting large holders are not buying the dip
  • XRP futures Open Interest dropped over 5% to $2.33 billion, pointing to reduced investor appetite

XRP is trading under pressure as the March 27 SEC spot ETF deadline approaches. Retail investors appear to be buying the dip, but whale activity remains quiet and exchange reserves are rising — a mix that signals caution in the near term.

xrp priceXRP Price

The broader crypto market has lost around 2% in total capitalization, now sitting at $2.36 trillion. Bitcoin has stayed below $70,000 during this stretch.

XRP fell 3.52% over the weekend to around $1.40. The token failed to hold above the $1.45 resistance level, and selling pressure has pushed it below the $1.40 support zone.

On the technical side, the MACD histogram is showing bearish signals. The signal line has crossed below the MACD line, confirming the current downward trend in the short term.

Key support is sitting near $1.38. If that level breaks, traders are watching the $1.35 area as the next floor. A move back above $1.45 would be needed to shift sentiment, while clearing $1.50 would open the path toward the $1.55 resistance level.

SEC ETF Deadline: March 27

March 27 marks the SEC’s final deadline for a batch of outstanding XRP spot ETF applications. Pending applicants include Grayscale, 21Shares, Bitwise, Canary Capital, WisdomTree, and Franklin Templeton.

Grayscale is looking to convert its $2.1 billion XRP trust into a spot ETF. Franklin Templeton has proposed a 0.15% fee to stay competitive. Bloomberg analysts currently put the odds of at least one approval before year-end at 95%.

U.S.-based spot XRP investment vehicles have already attracted $1.44 billion, mostly from retail investors. Industry estimates suggest that institutional inflows could reach $8 billion if approvals come through, with pension funds and retirement accounts expected to be key sources of that capital.

ProShares already launched a 2x leveraged XRP ETF on NYSE Arca back in July 2025. And in March, the SEC and CFTC released a joint 68-page regulatory framework, categorizing XRP as a digital commodity alongside Bitcoin, Ethereum, Solana, Cardano, and Dogecoin.

On-Chain Retail Buying, Whales Sitting Still

Santiment data shows wallets holding under 100 XRP have hit a record 5.66 million. Wallets in the 100 to 100,000 XRP range also hit a record at 2.01 million. But wallets holding more than 100,000 XRP remain stagnant at 32,054, following a drop in early February.

This pattern often signals that retail buyers are providing exit liquidity for larger holders.

CryptoQuant data shows XRP reserves on Binance have risen to 2.79 billion XRP, up from 2.55 billion in early February. Rising exchange reserves typically point to increased sell pressure.

CoinGlass data puts XRP futures Open Interest at $2.33 billion, down more than 5% from $2.47 billion the previous day. Open Interest has been falling for most of 2026, pointing to reduced leveraged exposure.

XRP is currently down around 25% year-to-date.

The post XRP Price: Retail Buyers Step In but Whales Stay Quiet Before the Big SEC Decision appeared first on CoinCentral.

Market Opportunity
XRP Logo
XRP Price(XRP)
$1.372
$1.372$1.372
-1.47%
USD
XRP (XRP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

Synopsys (SNPS) Stock — Elliott Investment Builds Multibillion-Dollar Stake

TLDR Elliott Investment Management has built a multibillion-dollar stake in Synopsys (SNPS), per the WSJ. The activist firm wants Synopsys to generate more revenue
Share
Coincentral2026/03/23 17:00
Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale

BitcoinWorld Oil Demand Elasticity: Sobering Analysis Reveals Limited Price Relief Ahead – Societe Generale Global energy markets face a sobering reality in 2025
Share
bitcoinworld2026/03/23 17:05
Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11